What Form Does Praluent Come In?
Praluent (alirocumab) is an injection, not a pill. It's administered as a subcutaneous shot, typically every 2 or 4 weeks using a pre-filled pen or syringe.[1]
How Is Praluent Injected?
Patients self-inject Praluent into the abdomen, thigh, or upper arm. The 75 mg and 150 mg doses come in 1 mL pre-filled pens or syringes. No refrigeration is needed after first use; store at room temperature for up to 30 days.[1]
Why an Injection Instead of a Pill?
Praluent is a monoclonal antibody that targets PCSK9 to lower LDL cholesterol. Proteins like this degrade in the stomach, so injections deliver it directly into the bloodstream for effectiveness.[1][2]
How Does It Compare to Pill-Based Cholesterol Drugs?
Unlike daily pills such as statins (e.g., atorvastatin) or ezetimibe, Praluent requires fewer doses but needs injections. Statins are oral and cheaper generics; Praluent is for patients not controlled by pills alone.[1][2]
Common Patient Questions on Use